These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30887189)

  • 41. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.
    Schaefer C; Wuillemin WA; Kessels A; Jacobson A; Nagler M
    Br J Haematol; 2016 Nov; 175(4):677-685. PubMed ID: 27468696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dental and oral surgical treatment of medication-induced bleeding patients: Audit of the national guideline in Hungary].
    Lukács D; Stáczer N; Vajta L; Olasz L; Joób-Fancsaly Á; Szalma J
    Orv Hetil; 2016 Oct; 157(43):1722-1728. PubMed ID: 27774803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.
    Bartoli-Abdou JK; Patel JP; Crawshaw J; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
    Thromb Res; 2018 Feb; 162():62-68. PubMed ID: 29306122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).
    Di Minno A; Spadarella G; Tufano A; Prisco D; Di Minno G
    Thromb Res; 2014 May; 133(5):699-704. PubMed ID: 24525314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal Agents for the Direct Oral Anticoagulants.
    Ansell JE
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Zirlik A; Bode C
    J Thromb Thrombolysis; 2017 Apr; 43(3):365-379. PubMed ID: 27896543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials.
    Raccah BH; Perlman A; Danenberg HD; Pollak A; Muszkat M; Matok I
    Chest; 2016 Jun; 149(6):1516-24. PubMed ID: 26836922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of direct oral anticoagulants in the perioperative setting.
    Untereiner O; Seince PF; Chterev V; Leblanc I; Berroëta C; Bourel P; Philip I
    J Cardiothorac Vasc Anesth; 2015; 29(3):741-8. PubMed ID: 26009288
    [No Abstract]   [Full Text] [Related]  

  • 52. Direct oral anticoagulants in oral surgery: a prospective cohort.
    Rocha AL; Oliveira SR; Souza AF; Travassos DV; Abreu LG; Ribeiro DD; Silva TA
    Minerva Stomatol; 2020 Dec; 69(6):384-393. PubMed ID: 32698567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
    Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
    Chan NC; Eikelboom JW; Weitz JI
    Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study.
    Mauprivez C; Khonsari RH; Razouk O; Goudot P; Lesclous P; Descroix V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):e146-e155. PubMed ID: 27554378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Argentine Consensus in effective management of anticoagulation clinics for the use of vitamin k antagonists].
    Ceresetto JM; Duboscq C; Korin J; Fondevila C; Casais P; Rossi A; Scazziota A; Martinuzzo M; Aris Cancela ME; Rosa C; Pombo G; Guimelli C; Adamczuk Y; Martí A; Penchasky D; Riveros D; Puente D; Celebrin L; Molnar S; Meschengieser S; Castro Ríos M; Blanco A; Hendler H; Brodsky A; Sánchez Luceros A; Negri Aranguren P; Fedele JL; Merlo C; Raña P; Gumpel C; Colorio C; Grand B; Canónico V; Rossi E; Colimodio P; Orlando S; Fassi D; Arias M; Viudez L; Farreras R; Martínez P; Ferro H; Casali C; Baques A; Arbesú G; Viñuales S; Medina F; Cortés V; Gallo MDC; Ehelou L; Barrera L; Rey I; de Larrañaga G; Figueroa F; Vilaseca A; Kuri I; Maneyro A; Otaran M; Xavier DL; Garbiero S; Salviú J; Fontenla P; Eckhardt A; Bomparola C; Fornasiero L
    Medicina (B Aires); 2020; 80 Suppl 4():1-26. PubMed ID: 32897867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation.
    Zhao Y; Lu Y; Qin Y
    Int J Cardiol; 2018 Nov; 270():167-171. PubMed ID: 29903520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study to assess management of patients on warfarin by general dental practitioners (GDPs) in the West Midlands.
    Dewan K; Vithlani V; Patel N; Warren K
    Dent Update; 2012 Oct; 39(8):578-80, 583-4, 586-7. PubMed ID: 23167207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
    Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.